1.
Miyakawa J, Taguchi S, Suzuki M, Endo K, Nose Y, Sato T, et al. Impact of Monthly 120 Mg Denosumab on Bone Metabolism in Bone-metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy. Asian Pac J Cancer Care [Internet]. 2017 Jun. 12 [cited 2026 May 29];2(3):41-6. Available from: http://www.waocp.com/journal/index.php/apjcc/article/view/58